Phytochemistry, Anti-Diabetics And Anti-Cancer Properties Of Betula Utilis
Bhau Sandeep, Dr.Arti Chaurasia
phytochemicals, anticancer medication, anti-diabetic, cancer cells.
The plant known as betula has a wide range of applications due to its adaptability and versatility. The D. Don tree, which is a member of the Betulaceae family and has a very long lifetime, has been referred to in Sanskrit for around four centuries as the Himalayan birch, bhojpatra, or Bhurja. This name comes from the fact that the D. Don tree is a member of the family Betulaceae. It is common known that the plant, when prepared in a medicinal form, has potential efficacy. A recent surge in attention in the use of birch bark as a possible therapy for cancer may be attributed to the high concentration of triterpenoids found in birch bark. These triterpenoids include betulinic acid and oleanolic acid, amongst others. Cancer cells are the target of the anticancer drug known as betulinic acid, which is responsible for their death. As a direct result of this, it set itself apart from several other alternative therapies for cancer. It has been shown that several species of the genus B. utilis contain both phenolic and flavonoid compounds. In addition to detecting the ability of phytochemicals to attach themselves to cancer cells, the SRB test is used to examine whether or not phytochemicals had anticancer properties when tested in a range of different solvents.
Article Details
Unique Paper ID: 156148

Publication Volume & Issue: Volume 9, Issue 2

Page(s): 39 - 48
Article Preview & Download

Share This Article

Join our RMS

Conference Alert

NCSEM 2024

National Conference on Sustainable Engineering and Management - 2024

Last Date: 15th March 2024

Call For Paper

Volume 10 Issue 10

Last Date for paper submitting for March Issue is 25 June 2024

About Us enables door in research by providing high quality research articles in open access market.

Send us any query related to your research on

Social Media

Google Verified Reviews